Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer’s Disease

Posted on by

—Data from 479-Patient Study Confirms Strong Prognostic Utility of AlzoSure® Predict for Identifying Whether or Not Individuals Will Experience a Significant Cognitive Decline due to Alzheimer’s Disease (AD) Within a 2-Year or 6-Year Timeframe— —Ability to Identify “Rapid Progressors” Who…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.